CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...